186 related articles for article (PubMed ID: 7473182)
1. Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive rats.
Casati C; Monopoli A; Forlani A; Bonizzoni E; Ongini E
J Pharmacol Exp Ther; 1995 Nov; 275(2):914-9. PubMed ID: 7473182
[TBL] [Abstract][Full Text] [Related]
2. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
Casati C; Monopoli A; Dionisotti S; Zocchi C; Bonizzoni E; Ongini E
J Pharmacol Exp Ther; 1994 Mar; 268(3):1506-11. PubMed ID: 8138961
[TBL] [Abstract][Full Text] [Related]
3. Humoral effects of selective adenosine agonists in spontaneously hypertensive rats.
Sala C; Monopoli A; Alberti C; Casati C; Ongini E; Zanchetti A; Morganti A
J Hypertens; 1996 Jan; 14(1):75-9. PubMed ID: 12013498
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.
Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E
Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
Webb RL; Barclay BW; Graybill SC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.
Casati C; Forlani A; Lozza G; Monopoli A
Pharmacol Res; 1997 Jan; 35(1):51-5. PubMed ID: 9149316
[TBL] [Abstract][Full Text] [Related]
7. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.
Conti A; Lozza G; Monopoli A
Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581
[TBL] [Abstract][Full Text] [Related]
8. Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
Webb RL; Sills MA; Chovan JP; Peppard JV; Francis JE
J Pharmacol Exp Ther; 1993 Oct; 267(1):287-95. PubMed ID: 8229754
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart.
Lozza G; Conti A; Ongini E; Monopoli A
Pharmacol Res; 1997 Jan; 35(1):57-64. PubMed ID: 9149317
[TBL] [Abstract][Full Text] [Related]
10. Mechanism and pressor relevance of the short-term cardiovascular and renin excitatory actions of the selective A2A-adenosine receptor agonists.
Alberti C; Monopoli A; Casati C; Forlani A; Sala C; Nador B; Ongini E; Morganti A
J Cardiovasc Pharmacol; 1997 Sep; 30(3):320-4. PubMed ID: 9300315
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat.
Monopoli A; Casati C; Lozza G; Forlani A; Ongini E
J Pharmacol Exp Ther; 1998 Apr; 285(1):9-15. PubMed ID: 9535988
[TBL] [Abstract][Full Text] [Related]
12. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
Levens N; Beil M; Jarvis M
J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017
[TBL] [Abstract][Full Text] [Related]
13. Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat.
Adami M; Bertorelli R; Ferri N; Foddi MC; Ongini E
Eur J Pharmacol; 1995 Dec; 294(2-3):383-9. PubMed ID: 8750698
[TBL] [Abstract][Full Text] [Related]
14. Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats.
Genovesi S; Pieruzzi F; Camisasca P; Ragonesi G; Protasoni G; Golin R; Zanchetti A; Stella A
J Cardiovasc Pharmacol; 2000 Feb; 35(2):189-94. PubMed ID: 10672849
[TBL] [Abstract][Full Text] [Related]
15. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
Schindler CW; Karcz-Kubicha M; Thorndike EB; Müller CE; Tella SR; Ferré S; Goldberg SR
Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
[TBL] [Abstract][Full Text] [Related]
17. Hypotensive and renal vasodilator effects of carbocyclic adenosine (aristeromycin) in anesthetized spontaneously hypertensive rats.
Dunham EW; Vince R
J Pharmacol Exp Ther; 1986 Sep; 238(3):954-9. PubMed ID: 3018227
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.
Monopoli A; Conti A; Dionisotti S; Casati C; Camaioni E; Cristalli G; Ongini E
Arzneimittelforschung; 1994 Dec; 44(12):1305-12. PubMed ID: 7848348
[TBL] [Abstract][Full Text] [Related]
19. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
[TBL] [Abstract][Full Text] [Related]
20. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones.
Nörenberg W; Wirkner K; Illes P
Br J Pharmacol; 1997 Sep; 122(1):71-80. PubMed ID: 9298530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
